Page last updated: 2024-11-02

oxymetazoline and Acne

oxymetazoline has been researched along with Acne in 3 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Research Excerpts

ExcerptRelevanceReference
"Oxymetazoline (OXZ) is a synthetic, direct-acting, sympathomimetic agonist that is highly selective for the 1α-adrenoceptor."7.11Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial. ( Agamia, N; Essawy, M; Kassem, A, 2022)
"Oxymetazoline (OXZ) is a synthetic, direct-acting, sympathomimetic agonist that is highly selective for the 1α-adrenoceptor."3.11Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial. ( Agamia, N; Essawy, M; Kassem, A, 2022)
"Oxymetazoline (OXZ) is a synthetic, highly selective agonist for alpha 1A-adrenoceptor."1.72A split face comparative study using a novel triple combination therapy for the treatment of persistent post acne erythema. ( Agamia, N; El-Ariny, A; El-Nagdy, S, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Agamia, N2
El-Nagdy, S1
El-Ariny, A1
Washrawirul, C1
Puaratana-Arunkon, T1
Chongpison, Y1
Noppakun, N1
Asawanonda, P1
Kumtornrut, C1
Essawy, M1
Kassem, A1

Trials

2 trials available for oxymetazoline and Acne

ArticleYear
The role of the topical nasal decongestant oxymetazoline as a novel therapeutic option for post-acne erythema: A split-face, double-blind, randomized, placebo-controlled trial.
    The Journal of dermatology, 2023, Volume: 50, Issue:6

    Topics: Acne Vulgaris; Adult; Double-Blind Method; Erythema; Humans; Nasal Decongestants; Oxymetazoline; Tha

2023
Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial.
    The Journal of dermatological treatment, 2022, Volume: 33, Issue:2

    Topics: Acne Vulgaris; Administration, Topical; Adrenergic alpha-Agonists; Erythema; Face; Humans; Oxymetazo

2022

Other Studies

1 other study available for oxymetazoline and Acne

ArticleYear
A split face comparative study using a novel triple combination therapy for the treatment of persistent post acne erythema.
    Dermatologic therapy, 2022, Volume: 35, Issue:4

    Topics: Acne Vulgaris; Administration, Topical; Brimonidine Tartrate; Drug Therapy, Combination; Erythema; H

2022